Valneva SE (VLA) | Stock Overview & Key Data
Valneva SE | Mid-cap | Healthcare
Valneva SE | Mid-cap | Healthcare
Valneva SE Performance Comparison
Stock Range
Today's Range
Low: €4.17
High: €4.40
on September 18, 2025
52 Week Range
Low: €1.73
High: €5.41
on December 16, 2024
on August 18, 2025
All-Time High: €29.70 on November 29, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€649.1M
EPS
-0.46
P/E Ratio (TTM)
70.64
Forward P/E
-10.22
P/B Ratio
3.38
PEG Ratio
-10.22
Div. Yield
N/A
ROE
-38.02%
Beta
1.014
Debt to Equity
105.63
Financial Highlights
Profitability
Gross Margin
50.10%
Operating Margin
-22.01%
Profit Margin
-34.15%
Returns and Earnings
Return on Assets (TTM)
-6.58%
Return on Equity (TTM)
-38.02%
EBITDA
€35.0M
Net Income (TTM)
€-67.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€1.21
Quarterly Revenue Growth (YoY)
27.00%
Quarterly Earnings Growth (YoY)
26.98%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Valneva SE VLA | 649.14M Mid-cap | 9.77% | -15.78% | 75.72% | 31.79% | 84.85% | 68.77% | -24.82% | -38.21% |
| Abivax SA ABVX | 5.26B Large-cap | -2.51% | 17.09% | 1,221.36% | 1,109.34% | 860.16% | 587.99% | 724.29% | 282.39% |
| Medincell S.A MEDCL | 656.19M Mid-cap | 8.48% | 20.64% | 28.19% | 46.12% | 20.30% | 30.41% | 287.16% | 201.43% |
| Inventiva S.A IVA | 626.50M Mid-cap | -5.07% | 23.01% | 55.90% | 63.87% | 112.80% | 149.44% | 9.78% | -54.42% |
| BNP Paribas Easy BLUE | 463.10M Mid-cap | 0.25% | 1.01% | 0.57% | 2.70% | -2.32% | -2.44% | 14.78% | 54.29% |
| Nanobiotix NANO | 416.19M Mid-cap | 27.14% | 45.23% | 181.77% | 211.82% | 252.44% | 139.91% | 194.02% | 82.46% |
Ownership & Short Interest
Insider Ownership
11.61%
Institutional Ownership
23.03%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VLA's 52-week high and low?
- In the last 52 weeks, Valneva SE reached a high of €5.41 (on August 18, 2025) and a low of €1.73 (on December 16, 2024).
- What is the market cap and P/E ratio for VLA?
- Curious about Valneva SE's size and valuation? Its market capitalization stands at 649.14M. When it comes to valuation, the P/E ratio (trailing twelve months) is 70.64, and the forward P/E (looking ahead) is -10.22.
- Does VLA pay dividends? If so, what's the yield?
- As for dividends, Valneva SE isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Valneva SE's main competitors or similar companies to consider before investing?
When looking at Valneva SE, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abivax SA
ABVX5.26B Healthcare Biotechnology 587.99% 724.29% Medincell S.A
MEDCL656.19M Healthcare Biotechnology 30.41% 287.16% Inventiva S.A
IVA626.50M Healthcare Biotechnology 149.44% 9.78% BNP Paribas Easy
BLUE463.10M Healthcare Biotechnology -2.44% 14.78% Nanobiotix
NANO416.19M Healthcare Biotechnology 139.91% 194.02% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Valneva SE? (e.g., ROE, Debt/Equity)
- To get a sense of Valneva SE's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -38.02%, the Debt to Equity ratio from the most recent quarter is 105.63, and its Gross Profit Margin stands at 50.10%.
- What is the recent revenue and earnings growth for VLA?
- Looking at Valneva SE's growth, its revenue over the trailing twelve months (TTM) was €196M. Compared to the same quarter last year (YoY), quarterly revenue grew by 27.00%, and quarterly earnings saw a YoY growth of 26.98%.
- How much of VLA stock is held by insiders and institutions?
- Wondering who owns Valneva SE stock? Company insiders (like executives and directors) hold about 11.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 23.03%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.